Replies to post #14729 on GTC Biotherapeutics (fka GTCB)

[kris_kade]

Obviously this is a blessing in disguise in the sense the need to do RS no longer exists. Assuming they somehow come with enough cash to last until Atryn is approved in Feb 2009, RS may never need to happen.